Rep. Lisa C. McClain Buys Humana Inc. (NYSE:HUM) Stock

Representative Lisa C. McClain (R-Michigan) recently bought shares of Humana Inc. (NYSE:HUM). In a filing disclosed on October 22nd, the Representative disclosed that they had bought between $1,001 and $15,000 in Humana stock on September 25th. The trade occurred in the Representative’s “CHARLES SCHWAB BROKERAGE ACCOUNT 924” account.

Representative Lisa C. McClain also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of FMC (NYSE:FMC) on 9/25/2025.
• Sold $1,001 – $15,000 in shares of Merit Medical Systems (NASDAQ:MMSI) on 9/25/2025.
• Purchased $1,001 – $15,000 in shares of Darden Restaurants (NYSE:DRI) on 9/25/2025.
• Purchased $1,001 – $15,000 in shares of ASML (NASDAQ:ASML) on 9/25/2025.
• Purchased $1,001 – $15,000 in shares of Kenvue (NYSE:KVUE) on 9/25/2025.
• Sold $1,001 – $15,000 in shares of Beacon Financial (NYSE:BBT) on 9/25/2025.
• Sold $1,001 – $15,000 in shares of British American Tobacco (NYSE:BTI) on 9/25/2025.
• Purchased $1,001 – $15,000 in shares of Rollins (NYSE:ROL) on 9/25/2025.
• Purchased $1,001 – $15,000 in shares of SAP (NYSE:SAP) on 9/25/2025.
• Purchased $1,001 – $15,000 in shares of MGP Ingredients (NASDAQ:MGPI) on 9/25/2025.

Humana Stock Up 1.2%

Shares of NYSE:HUM opened at $291.14 on Friday. The company has a 50 day moving average price of $281.57 and a two-hundred day moving average price of $259.05. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95. Humana Inc. has a 52 week low of $206.87 and a 52 week high of $315.35. The company has a market capitalization of $35.01 billion, a PE ratio of 22.34, a PEG ratio of 1.68 and a beta of 0.42.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a return on equity of 13.67% and a net margin of 1.28%.The company had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. During the same period in the prior year, the company earned $6.96 EPS. The firm’s revenue was up 9.6% on a year-over-year basis. Humana has set its FY 2025 guidance at 17.000- EPS. Analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.2%. The ex-dividend date of this dividend is Friday, September 26th. Humana’s dividend payout ratio is presently 27.17%.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on HUM. Barclays lowered their price objective on shares of Humana from $315.00 to $245.00 and set an “equal weight” rating for the company in a research report on Friday, October 3rd. Morgan Stanley lowered their price objective on shares of Humana from $290.00 to $277.00 and set an “equal weight” rating for the company in a research report on Thursday, July 31st. Wells Fargo & Company increased their price objective on shares of Humana from $344.00 to $347.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 7th. Guggenheim reissued a “buy” rating on shares of Humana in a research report on Friday, October 3rd. Finally, Wall Street Zen downgraded shares of Humana from a “buy” rating to a “hold” rating in a research report on Saturday, August 2nd. Eight research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $297.58.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Cary Street Partners Investment Advisory LLC grew its position in Humana by 63.9% in the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock valued at $31,000 after purchasing an additional 46 shares in the last quarter. Elevation Point Wealth Partners LLC acquired a new stake in Humana in the second quarter valued at $32,000. Mather Group LLC. acquired a new stake in Humana in the third quarter valued at $34,000. Zions Bancorporation National Association UT acquired a new stake in Humana in the first quarter valued at $37,000. Finally, AlphaCore Capital LLC acquired a new stake in Humana in the second quarter valued at $39,000. Institutional investors own 92.38% of the company’s stock.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.

Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.